Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data

OBJECTIVESTo determine the real-life efficacy, safety, and drug-retention rates of leflunomide (LEF) or methotrexate (MTX) as a synthetic DMARD used in combination with biological DMARDs for rheumatoid arthritis (RA). METHODSThe TReasure database is a web-based, prospective, observational cohort of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and Experimental Rheumatology 2021-07, Vol.39 (4), p.852-858
Hauptverfasser:	Kimyon, Gezmiş, Kalyoncu, Umut, Kiraz, Sedat, Bes, Cemal, Coşkun, Nihan, Yağiz, Burcu, Küçükşahin, Orhan, Kanitez, Nilüfer, Erden, Abdulsamet, Kiliç, Levent, Bilgin, Emre, Kaşifoğlu, Timuçin, Emmungil, Hakan, Koca, Süleyman Serdar, Akar, Servet, Çinar, Muhammet, Yazisiz, Veli, Ateş, Aşkın, Ersözlü, Duygu, Gönüllü, Emel, Mercan, Rıdvan, Ertenli, İhsan
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!